Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial.
Tomas ReischigMartin KacerPetra HrubaHana HermanovaOndrej HesDaniel LysakStanislav KormundaMirko BoudaPublished in: BMC infectious diseases (2018)
Australian New Zealand Clinical Trials Registry ( ACTRN12610000016033 ). Registered on September 26, 2007.